Finck Barbara K
- SEC CIK
- 0001242116
No open-market purchases or sales filed in the past year.
Current role at each company
- FBRX Forte Biosciences, Inc.Directoras of Aug 27, 2026
- CMRA Comera Life Sciences Holdings, Inc.Directoras of Feb 14, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Finck Barbara K as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CMRA Comera Life Sciences Holdings, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 14, 2023 (view filing)5:34 PM ET | Jan 4 | 41 days | Finck Barbara KDirector | PPurchase | +6.76K | $1.23 | +$8.31K | +41.5%23.0K after | Amended |
| Feb 14, 2023 (view filing)5:34 PM ET | Jan 4 | 41 days | Finck Barbara KDirector | PPurchase | +13.5K | $0.125 | +$1.69K | –6.76K after | AmendedDerivative |